Confluence Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,368
Closed -$206K 125
2017
Q3
$206K Buy
+3,368
New +$204K 0.1% 120
2015
Q4
Sell
-4,438
Closed -$209K 132
2015
Q3
$209K Buy
4,438
+224
+5% +$11.9K 0.11% 115
2015
Q2
$229K Buy
4,214
+5
+0.1% +$280 0.13% 101
2015
Q1
$231K Buy
+4,209
New +$238K 0.13% 99
2014
Q3
Sell
-14,635
Closed -$808K 102
2014
Q2
$808K Buy
+14,635
New +$798K 0.46% 55

Other funds holding MRK

Confluence Wealth Management's MRK Position: Q4 2017 in Review

Confluence Wealth Management sold out of Merck (MRK) in Q4 2017, closing a stake of 3,368 shares — an estimated $206K sold.

Confluence Wealth Management first reported a position in MRK in Q2 2014 and held it in 5 quarters. The position peaked at $808K in Q2 2014. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Confluence Wealth Management reported no remaining Merck position as of Q4 2017 after selling out during the quarter.
  • Confluence Wealth Management sold 3,368 Merck shares in Q4 2017, an estimated $206K.
  • Confluence Wealth Management first reported a position in Merck in Q2 2014 and held it in 5 quarters.
  • Confluence Wealth Management's Merck position peaked at $808K in Q2 2014.
  • 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Confluence Wealth Management's 13F filing for Q4 2017, filed 7 Feb 2018.